Plasma Treated MDI Canisters

Plasma Technology from Presspart

Presspart has developed a revolutionary sub-micron plasma technology process for treating the internal surface of metered-dose inhaler canisters.

The Presspart plasma treatment process improves the surface energy properties of an MDI canister, thus helping to prevent the active content of a drug formulation adhering to the canister wall. This ensures that the patient receives the prescribed dose and solves an inherent problem present within many of today’s metered dose inhalers.

There is also the added benefit of enhanced drug stability performance, in formulations where interactions with the aluminium substrate can lead to product degradation and reduced shelf life.

Advantages of Presspart’s plasma treatment for metered dose inhaler canisters:

  • Uses ultra-pure monomers (99.99% purity).
  • No solvents or other waste products produced.
  • No resulting extractable or leachable material.
  • Canisters are cleaned during the plasma process.
  • Surface treatment fully replicates the contours of the canister.
  • Low surface energy polymerised nanolayer for high degree of repellency.
  • Scalable volume process with excellent cycle to cycle repeatability.
  • No need for post treatment baking at high temperature.

Contact us to discuss the options for plasma treatment or to learn more about Presspart’s plasma technology. To see more information on our plasma process, download the information sheet.

MDI canister plasma

MDI cans

About Presspart

About Presspart Drawing on 42 years of success, Presspart Manufacturing Ltd has developed in to a World-leader of bespoke deep-drawn and injection moulded components, with manufacturing plants located across the Globe. Presspart's ability to offer customers a unique service in toolmaking, design and development skills has been the foundation for more than four decades of successful … read more

Inhalation Product Technology Centre from Presspart

Inhalation Product Technology Centre (IPTC)

Inhalation Product Technology Centre (IPTC) from Presspart Supporting the strategic projects of Presspart and our customers Here at Presspart Manufacturing, we have further expanded our research and development capabilities with the introduction of an Inhalation Product Technology Centre (IPTC). As the world’s leading manufacturer of components for metered dose inhalers, including MDI canisters … read more

MDI Cans

Manufacturing an MDI canister

Manufacturing a metered-dose inhaler canister How Presspart manufactures over 600 million metered-dose inhaler canisters for the pharmaceutical market every year. The following short video shows how Presspart manages to manufacture over 75% of the world's metered-dose inhaler canisters every year. … read more


CPhi Russia 2016

First time at CPhi Russia for Presspart Presspart, the leading supplier of respiratory drug delivery components, will be exhibiting for the first time at CPhi Russia, Moscow on stand 234 from the 30th March- 1st April 2016 CPhI Russia is a content-led exhibition and networking event which hosts a range of exhibitors in the field of pharma ingredients, finished dosage, machinery, equipment, … read more

© Copyright Presspart Manufacturing Ltd. All Rights Reserved | Whitebirk Ind. Est. Blackburn, Lancashire, BB1 5RF United Kingdom Tel: +44 (0)1254 582233 | Site:
Privacy Policy | Imprint